BIOGEN

Insurance companies are weighing whether to cover Biogen’s controversial new drug for Alzheimer’s disease, which has an annual cost of $56,000.

The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug

A month after approving a controversial new Alzheimer’s drug, the FDA has signed off on new prescribing instructions to limit its use to only patients with early or mild cases of the disease. The acting head of the FDA, Dr. Janet Woodcock, also announced that she was ordering an investigation into whether the agency acted improperly in approving the...

Doctors are trying to figure out who should get a new treatment for Alzheimer’s disease

There is new hope for Alzheimer’s patients and their families with a new drug from Biogen approved by the FDA, but controversy is swarming around the very expensive treatment. The TEN talks to experts and doctors.

The FDA has approved a controversial drug for Alzheimer’s disease developed by Cambridge-based pharmaceutical company Biogen.

More than a year after Biogen held multi-day management meetings that became a global superspreader event in the COVID-19 pandemic, newly released emails show the extent of the fear and confusion among the drug makers’ employees in those early days, as testing shortages, miscommunication from the state and changing guidance from health care professionals plagued the response. The emails also…

One year ago this weekend, more than 100 people from around the world convened at the Boston Marriott Long Wharf hotel for a biotech leadership conference led by the Cambridge-based biotech company Biogen. At the time, the novel coronavirus SARS-CoV-2 was widely known to be circulating. The World Health Organization had already declared the virus and the disease it caused…

A biotech conference held at a Boston hotel in late February that had already been blamed for the initial spread of the coronavirus in eastern Massachusetts has now been tied to hundreds of thousands of cases of the virus globally. The two-day Biogen conference at the Boston Marriott Long Wharf hotel is responsible for infecting as many as 330,000 people…

More than 300,000 coronavirus cases have been linked to a Biogen leadership conference that was held in February at the Marriott Long Wharf in Boston, according to a new study.

Government health advisers have sharply criticized an experimental Alzheimer’s drug

There are now 328 total coronavirus cases in Massachusetts, up 72 from a day earlier. It’s the largest spike since the number of cases jumped from 41 to 92 back on March 10, the same day Gov. Charlie Baker declared a state of emergency. Massachusetts is one of the states in the U.S. with the most coronavirus cases in the…

Biogen, the biotech company behind a cluster of coronavirus cases in Massachusetts and several other U.S. states, is committing $10 million to relief efforts in the commonwealth and elsewhere through its foundation. The $10 million the Biogen Foundation is donating “will be used to address immediate critical needs,” mainly in Massachusetts, North Carolina and Italy, for testing, training and health…

Massachusetts Gov. Charlie Baker on Friday announced announced a ban on gatherings of more than 250 people amid the outbreak of the novel coronavirus. Baker said in a news conference the state had issued guidance prohibiting such gatherings, which include leisure gatherings, faith-based events, sporting events with spectators, concerts, conventions. The order does not apply to normal operations at airports,…

Massachusetts Gov. Charlie Baker further discussed the state’s coronavirus preparedness on Friday while also announcing a ban on gatherings of more than 250 people.

The Marriott Long Wharf hotel in Boston was closed indefinitely, days after it was determined that a company’s meeting there was the center of a coronavirus cluster.

The Boston hotel that hosted the Biogen conference at the center of the Massachusetts coronavirus outbreak says it is closing “in the interest of public health.” The hotel said in a statement that the decision to close the Marriott Long Wharf hotel was made in consultation with the Boston Public Health Commission in response to “new information.” There was no…

Seventy-seven of the 95 confirmed cases in Massachusetts have been linked to a meeting of executives with Biogen, a company based in Cambridge, next to Boston, that develops therapies for neurological diseases, state officials said.

Ninety-two coronavirus cases have been reported in Massachusetts thus far, and the majority of them have been linked to a conference held by the biotech company Biogen. Here’s everything we know about the conference and the presumptive COVID-19 cases that resulted: Biogen is a 42-year-old biopharmaceutical company that has created treatments for diseases and conditions like Alzheimer’s and multiple...

A second person in Indiana has tested positive for COVID-19 after traveling to Boston to attend a biotech firm’s meeting, state officials said Sunday.